Mineralys Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $84,657,000.
Profit Margin
| 2020 | 0 | -3.42M | |
|---|---|---|---|
| 2021 | 0 | -19.40M | |
| 2022 | 0 | -29.79M | |
| 2023 | 0 | -71.89M |
MLYS Income Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 |
Operating exp. | ||||
Research and development | 70.36M | 26.25M | 16.30M | 2.41M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 84.65M | 31.47M | 18.72M | 2.94M |
Operating income | -84.65M | -31.47M | -18.72M | -2.94M |
Other income (expenses), net | 12.75M | 4K | -656K | -483K |
Income before tax | -71.89M | -29.79M | -19.40M | -3.42M |
Income tax expense | 0 | 0 | 27K | 115K |
Net income | -71.89M | -29.79M | -19.40M | -3.42M |
Earnings per share | ||||
Basic EPS | -1.99 | -0.73 | -0.5 | -0.08 |
Diluted EPS | -1.99 | -0.73 | -0.5 | -0.08 |
| Data source | Data source |